HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS

被引：0
作者：
Bergstein, Suzannah
Spencer, Elizabeth
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [41] Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis
    Antonatos, Charalabos
    Stavrou, Eleana F.
    Evangelou, Evangelos
    Vasilopoulos, Yiannis
    PHARMACOGENOMICS, 2021, 22 (07) : 435 - 445
  • [42] Hypergammaglobulinemia, hypoalbuminemia, and elevated CRP levels are predictors of a secondary loss of response to anti-TNFα therapy in IBD
    Schoenefuss, F.
    Hoffmann, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S362 - S363
  • [43] Impact of HLA-DQA1*05 genotype in immunogenicity and response to treatment with Tumour Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease patients
    Torres, V. Moreno
    Mira, C.
    Madero-Velazquez, L.
    Munoz, R.
    Belen-Galipienso, O.
    Cameo, J., I
    Bernal, L.
    Garcia-Trueba, A.
    Sempere, L.
    Gutierrez-Casbas, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2352 - i2353
  • [44] HLA-DQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease (vol 51, pg 356, 2020)
    Wilson, A.
    Peel, C.
    Wang, Q.
    Pananos, Ad
    Kim, Rb
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (09) : 1220 - 1220
  • [45] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [46] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [47] Meta-analysis of efficacy of anti-TNF alpha therapy in ankylosing spondylitis patients
    Montilla Salas, Juan
    Munoz Gomariz, Elisa
    Collantesa, Eduardo
    REUMATOLOGIA CLINICA, 2007, 3 (05): : 204 - 212
  • [48] The Relapse Rate of Inflammatory Bowel Disease (IBD) in Patients Who Discontinue Anti-TNF Therapy: A Systematic Review and Meta-Analysis
    Ebrahimi, Fatemeh
    Torkian, Samaneh
    Zare-Farashbandi, Elahe
    Tamizifar, Babak
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (09) : 1976 - 1991
  • [49] Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease
    Yun Qiu
    Bai-li Chen
    Ren Mao
    Sheng-hong Zhang
    Yao He
    Zhi-rong Zeng
    Shomron Ben-Horin
    Min-hu Chen
    Journal of Gastroenterology, 2017, 52 : 535 - 554
  • [50] Meta-Analysis Identifies Major Histocompatiblity Complex Loci in or Near HLA-DRB1, HLA-DQA1, HLA-C as Associated with Leprosy in Chinese Han Population
    Zhang, Xuelei
    Cheng, Yuyan
    Zhang, Qun
    Wang, Xiaomeng
    Lin, Yan
    Yang, Chao
    Sun, Jingying
    Huang, He
    Li, Yang
    Sheng, Yujun
    Fan, Xing
    Sun, Yonghu
    Zhang, Xuejun
    Zheng, Xiaodong
    Zhang, Bo
    Yang, Sen
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (04) : 957 - 960
12345